Kerala govt data busts COVID-vaccine death myth
As per the data, mortality rates in this group have remained relatively consistent, at 3.30% in 2019 and at 3.13% and 3.23% in the post-vaccination years of 2022 and 2023 respectively.
Indian scientists have developed a new technology platform for fluorometric detection of pathogens including the detection of SARS-CoV-2—that has caused the ongoing Covid-19 pandemic.
The Team of scientists also demonstrated the potential of the new technology for the detection of SARS-CoV-2.
“This technology platform can also be used to detect other DNA/RNA pathogens such as HIV, influenza, HCV, Zika, Ebola, bacteria, and other mutating/evolving pathogens,” said a senior officer of the Ministry of Science and Technology.
Advertisement
The scientists from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), along with scientists from IISc (India Institute of Science), demonstrated a non canonical nucleic acid-based G-quadruplex (GQ) topology targeted reliable conformational polymorphism (GQ-RCP) platform to diagnose Covid-19 clinical samples, the Ministry said.
This work has also been published recently in the prestigious journal ‘ACS Sensors’ and the team has also filed a patent for the novel technology. This molecular detection platform can be integrated into field-deployable isothermal amplification assays with more reliability and sequence specificity, the Ministry said.
“The platform lays greater emphasis on deciphering and systematic characterization of a unique set of interactions in nucleic acids to attain stable and reliable noncanonical DNA/RNA targets. The RCP-based target validation is a general and modular approach for the development of noncanonical nucleic acid-targeted diagnostic platforms for diverse pathogens, including bacteria and DNA/RNA viruses,” said a senior officer of the Ministry of Science and Technology.
The study conducted by the scientists has established a reliable strategy for fluorogenic organic molecule-based GQ-RCP platform to diagnose Covid-19 clinical samples and is the first practical demonstration of it, the Ministry said.
Advertisement
